Deferasirox in Indian children with thalassemia major: 3 years experience

OBJECTIVE: To evaluate the efficacy and safety of the oral iron chelator deferasirox in treating transfusional hemosiderosis in a cohort of Indian children with thalassemia major with high iron load. MATERIALS AND METHODS: The first 50 children (age 2-18 yrs) with thalassemia major to commence defer...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhamija, Mayank, Mahajan, Amita, Kalra, Manas, Virmani, Anju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715972/
https://www.ncbi.nlm.nih.gov/pubmed/23878481
http://dx.doi.org/10.4103/0971-5851.113407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715972/
https://www.ncbi.nlm.nih.gov/pubmed/23878481
http://dx.doi.org/10.4103/0971-5851.113407

Ejemplares similares